We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$658M
AUM Growth
+$41.6M
Cap. Flow
-$2.26M
Cap. Flow %
-0.34%
Top 10 Hldgs %
27.12%
Holding
136
New
3
Increased
48
Reduced
56
Closed
10

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.62M
2
YUM icon
Yum! Brands
YUM
+$1.59M
3
FDX icon
FedEx
FDX
+$1.53M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.47M
5
GLW icon
Corning
GLW
+$1.12M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.18M
2
CVX icon
Chevron
CVX
+$1.86M
3
META icon
Meta Platforms (Facebook)
META
+$1.69M
4
PXD
Pioneer Natural Resource Co.
PXD
+$1.02M
5
TELL
Tellurian Inc.
TELL
+$997K

Sector Composition

Rank Sector Weight
1 Technology 21.41%
2 Healthcare 18.95%
3 Industrials 13.46%
4 Communication Services 10.9%
5 Consumer Staples 10.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUM icon
51
Yum! Brands
YUM
$41.8B
$5.23M 0.79%
51,922
+15,391
+42% +$1.59M
EA icon
52
Electronic Arts
EA
$53B
$5.16M 0.78%
47,953
-2,203
-4% -$219K
CAT icon
53
Caterpillar
CAT
$375B
$5.04M 0.77%
34,127
-887
-3% -$124K
ABBV icon
54
AbbVie
ABBV
$443B
$5.03M 0.76%
56,842
+2,137
+4% +$177K
AXP icon
55
American Express
AXP
$227B
$4.95M 0.75%
39,753
-684
-2% -$81.7K
LH icon
56
Labcorp
LH
$25B
$4.89M 0.74%
33,683
+1,379
+4% +$199K
CMI icon
57
Cummins
CMI
$87.5B
$4.8M 0.73%
26,813
-4,366
-14% -$768K
SLB icon
58
SLB Ltd
SLB
$73.6B
$4.66M 0.71%
115,974
-12,715
-10% -$454K
MDT icon
59
Medtronic
MDT
$109B
$4.42M 0.67%
38,960
-1,993
-5% -$219K
LLY icon
60
Eli Lilly
LLY
$1.02T
$4.37M 0.66%
33,270
+1,284
+4% +$149K
GSK icon
61
GSK
GSK
$104B
$4.37M 0.66%
74,375
-3,467
-4% -$193K
NXPI icon
62
NXP Semiconductors
NXPI
$57.8B
$4.13M 0.63%
32,495
-975
-3% -$113K
HUBB icon
63
Hubbell
HUBB
$25B
$3.85M 0.58%
26,039
+1,250
+5% +$178K
BAX icon
64
Baxter International
BAX
$13.5B
$3.66M 0.56%
43,771
+2,050
+5% +$170K
BRK.B icon
65
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.6M 0.55%
15,883
+1,240
+8% +$269K
INTU icon
66
Intuit
INTU
$86.5B
$3.51M 0.53%
13,388
+1,105
+9% +$289K
MDLZ icon
67
Mondelez International
MDLZ
$79.5B
$3.42M 0.52%
62,073
-455
-0.7% -$24.3K
NVDA icon
68
NVIDIA
NVDA
$4.86T
$3.36M 0.51%
570,960
-29,800
-5% -$155K
BIIB icon
69
Biogen
BIIB
$30B
$2.8M 0.43%
+9,440
New +$2.62M
KO icon
70
Coca-Cola
KO
$377B
$2.65M 0.4%
47,983
+3,360
+8% +$181K
SNA icon
71
Snap-on
SNA
$21.2B
$2.57M 0.39%
15,185
-490
-3% -$79.9K
DT
72
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$2.54M 0.39%
155,692
-46,911
-23% -$764K
EMR icon
73
Emerson Electric
EMR
$83.9B
$2.49M 0.38%
32,614
-191
-0.6% -$13.8K
XOM icon
74
ExxonMobil
XOM
$644B
$2.41M 0.37%
34,593
-10,774
-24% -$745K
TGT icon
75
Target
TGT
$65.6B
$2.19M 0.33%
17,056
+1,500
+10% +$176K
1 2
3
4 5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs & Co held 136 positions worth $658M, up 6.8% from $617M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jacobs & Co's Q4 2019 filing shows 3 new, 48 increased, 56 reduced and 10 closed positions. Its largest new stake was Biogen: 9,440 shares worth $2.8M. The largest sale was Celgene Corp, an estimated $2.18M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2019 buy was Biogen: 9,440 shares worth $2.8M.
  • Jacobs & Co added most to Yum! Brands in Q4 2019, an estimated $1.59M increase.
  • Jacobs & Co's biggest Q4 2019 reduction was Chevron, cutting an estimated $1.86M.
  • Jacobs & Co fully exited Celgene Corp in Q4 2019, selling an estimated $2.18M.
  • Jacobs & Co's ten largest holdings make up 27% of its $658M portfolio in Q4 2019.
  • Jacobs & Co opened 3 new positions and closed 10 in Q4 2019.
  • Jacobs & Co's portfolio value rose 6.8% quarter-over-quarter to $658M.

Based on Jacobs & Co's 13F filing for Q4 2019, filed 29 Jan 2020.